SRRK

$0.00

(

+0.00%

)
Quote details

stock

Scholar Rock Holding Corp

NASDAQ | SRRK

32.47

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 18, 2025)

$3.07B

Market Cap

-

P/E Ratio

-2.92

EPS

$46.98

52 Week High

$6.76

52 Week Low

HEALTHCARE

Sector

SRRK Chart

Recent Chart
Price Action

SRRK Technicals

Tags:

SRRK Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$252M
Selling General And Administrative $68M
Research And Development $183M
Operating Expenses $252M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.9M
Income Before Tax -$246M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$246M
Comprehensive Income Net Of Tax -
Ebit -$239M
Ebitda -$238M
Net Income -$246M

Revenue & Profitability

Earnings Performance

SRRK Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $475M
Total Current Assets $451M
Cash And Cash Equivalents At Carrying Value $178M
Cash And Short Term Investments $178M
Inventory -
Current Net Receivables $2.2M
Total Non Current Assets $24M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $2.4M
Intangible Assets Excluding Goodwill $2.4M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $259M
Other Current Assets $12M
Other Non Current Assets -
Total Liabilities $106M
Total Current Liabilities $47M
Current Accounts Payable $10M
Deferred Revenue -
Current Debt -
Short Term Debt $5.8M
Total Non Current Liabilities $59M
Capital Lease Obligations $15M
Long Term Debt $50M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $65M
Other Current Liabilities $31M
Other Non Current Liabilities -
Total Shareholder Equity $369M
Treasury Stock -
Retained Earnings -$923M
Common Stock $94K
Common Stock Shares Outstanding $100M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$201M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.9M
Capital Expenditures $98K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$76M
Cashflow From Financing $353M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$246M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$252M
Selling General And Administrative $68M
Research And Development $183M
Operating Expenses $252M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.9M
Income Before Tax -$246M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$246M
Comprehensive Income Net Of Tax -
Ebit -$239M
Ebitda -$238M
Net Income -$246M

SRRK News

SRRK Profile

Scholar Rock Holding Corp Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Scholar Rock Holding Corporation is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to the development of innovative therapies targeting serious diseases influenced by protein growth factor signaling. The company employs a unique approach to unlock the therapeutic potential of the TGF-beta superfamily, with a robust pipeline focused on conditions such as muscular dystrophy and cancer. Scholar Rock aims to transform patient outcomes by advancing its specialized treatments through rigorous scientific research and strategic collaborations.

ADAP
+108.91%
$0.16
INTC
+23.05%
$30.64
DVLT
+17.15%
$0.40
CGBS
-39.47%
$0.03
NVDA
+3.49%
$176.24
AERT
+63.00%
$0.92
SNAP
+6.32%
$8.49
ATCH
-28.08%
$1.16
GPUS
+23.87%
$0.51
BITF
+4.42%
$3.18
LASE
+69.10%
$4.73
PLUG
+4.86%
$2.09
CDLX
+109.79%
$3.00
RGTI
+12.50%
$24.74
APVO
+38.96%
$1.95
AAL
+0.76%
$12.57
GRAB
+4.09%
$6.35
TSLA
-2.02%
$417.23
SOUN
+3.47%
$15.64
NEHC
-4.00%
$0.45
AMD
-0.81%
$157.85
RAYA
+27.06%
$0.05
ETNB
+85.08%
$14.95
MARA
+7.47%
$18.63
TPIC
-45.91%
$0.12
NIO
-0.65%
$7.40
AXDX
-61.36%
$0.03
YAAS
+14.04%
$0.07
QBTS
+8.31%
$24.41
BMNR
+4.78%
$59.80
PLTR
+4.78%
$176.38
TNMG
-0.27%
$0.32
BINI
-14.33%
$0.05
SOFI
+3.88%
$28.19
CLSK
+16.87%
$13.37
QS
+18.12%
$12.11
DNN
+0.59%
$2.55
F
+0.72%
$11.74
LYT
-16.77%
$0.09
NFE
+12.96%
$2.44
KDLY
-4.66%
$1.43
TLRY
+5.88%
$1.26
BTG
0.00%
$4.33
RR
+12.81%
$4.49
BBD
-1.05%
$3.27
AAPL
-0.46%
$237.88
IONQ
+1.22%
$66.23
MULN
-6.96%
$0.06
VHAI
0.00%
$0.00
RMBL
+60.50%
$3.21
RIVN
+5.42%
$14.87
QUBT
+4.06%
$18.43
ADD
-25.47%
$0.05
CIFR
-4.28%
$11.85
AMZN
-0.16%
$231.23
ONDS
+8.19%
$6.60
JOBY
+3.24%
$14.62
BURU
+5.71%
$0.14
SRM
+53.27%
$10.30
QSI
+21.82%
$1.53
WBD
+3.44%
$18.60
PFE
+0.35%
$24.13
ABEV
-2.45%
$2.30
RIG
-2.01%
$3.40
IXHL
+2.29%
$0.54
IONZ
-4.37%
$4.59
HIMS
+10.53%
$55.65
NVNI
+13.19%
$0.91
NOK
+1.38%
$4.76
HBAN
+1.88%
$17.87
FAAS
-10.53%
$0.08
ITUB
+1.82%
$7.27
HOOD
+2.24%
$121.29
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BEEM
+20.15%
$3.04
WULF
-1.86%
$11.13
WLGS
-5.57%
$0.04
SBET
+0.58%
$17.22
MU
+5.56%
$168.89
KEY
+2.16%
$19.11
OKLO
+10.10%
$104.92
AIRE
-10.40%
$1.12
ORIS
+11.11%
$0.15
VALE
-0.32%
$10.84
KVUE
-1.36%
$18.09
HL
-2.26%
$10.78
ETWO
0.00%
$3.30
NVTS
+4.17%
$6.73
RCAT
-10.91%
$10.03
ACHR
+2.50%
$9.22
SMCI
+2.31%
$45.94
NAKA
+3.50%
$1.48
BTBT
+2.97%
$3.12
PBM
+42.47%
$5.30
CAN
+1.23%
$0.81
RIOT
-0.19%
$17.58
BTE
-2.54%
$2.48
RXRX
+4.67%
$4.93
ORCL
-1.59%
$296.60
ADAP
+108.91%
$0.16
INTC
+23.05%
$30.64
DVLT
+17.15%
$0.40
CGBS
-39.47%
$0.03
NVDA
+3.49%
$176.24
AERT
+63.00%
$0.92
SNAP
+6.32%
$8.49
ATCH
-28.08%
$1.16
GPUS
+23.87%
$0.51
BITF
+4.42%
$3.18
LASE
+69.10%
$4.73
PLUG
+4.86%
$2.09
CDLX
+109.79%
$3.00
RGTI
+12.50%
$24.74
APVO
+38.96%
$1.95
AAL
+0.76%
$12.57
GRAB
+4.09%
$6.35
TSLA
-2.02%
$417.23
SOUN
+3.47%
$15.64
NEHC
-4.00%
$0.45
AMD
-0.81%
$157.85
RAYA
+27.06%
$0.05
ETNB
+85.08%
$14.95
MARA
+7.47%
$18.63
TPIC
-45.91%
$0.12
NIO
-0.65%
$7.40
AXDX
-61.36%
$0.03
YAAS
+14.04%
$0.07
QBTS
+8.31%
$24.41
BMNR
+4.78%
$59.80
PLTR
+4.78%
$176.38
TNMG
-0.27%
$0.32
BINI
-14.33%
$0.05
SOFI
+3.88%
$28.19
CLSK
+16.87%
$13.37
QS
+18.12%
$12.11
DNN
+0.59%
$2.55
F
+0.72%
$11.74
LYT
-16.77%
$0.09
NFE
+12.96%
$2.44
KDLY
-4.66%
$1.43
TLRY
+5.88%
$1.26
BTG
0.00%
$4.33
RR
+12.81%
$4.49
BBD
-1.05%
$3.27
AAPL
-0.46%
$237.88
IONQ
+1.22%
$66.23
MULN
-6.96%
$0.06
VHAI
0.00%
$0.00
RMBL
+60.50%
$3.21
RIVN
+5.42%
$14.87
QUBT
+4.06%
$18.43
ADD
-25.47%
$0.05
CIFR
-4.28%
$11.85
AMZN
-0.16%
$231.23
ONDS
+8.19%
$6.60
JOBY
+3.24%
$14.62
BURU
+5.71%
$0.14
SRM
+53.27%
$10.30
QSI
+21.82%
$1.53
WBD
+3.44%
$18.60
PFE
+0.35%
$24.13
ABEV
-2.45%
$2.30
RIG
-2.01%
$3.40
IXHL
+2.29%
$0.54
IONZ
-4.37%
$4.59
HIMS
+10.53%
$55.65
NVNI
+13.19%
$0.91
NOK
+1.38%
$4.76
HBAN
+1.88%
$17.87
FAAS
-10.53%
$0.08
ITUB
+1.82%
$7.27
HOOD
+2.24%
$121.29
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BEEM
+20.15%
$3.04
WULF
-1.86%
$11.13
WLGS
-5.57%
$0.04
SBET
+0.58%
$17.22
MU
+5.56%
$168.89
KEY
+2.16%
$19.11
OKLO
+10.10%
$104.92
AIRE
-10.40%
$1.12
ORIS
+11.11%
$0.15
VALE
-0.32%
$10.84
KVUE
-1.36%
$18.09
HL
-2.26%
$10.78
ETWO
0.00%
$3.30
NVTS
+4.17%
$6.73
RCAT
-10.91%
$10.03
ACHR
+2.50%
$9.22
SMCI
+2.31%
$45.94
NAKA
+3.50%
$1.48
BTBT
+2.97%
$3.12
PBM
+42.47%
$5.30
CAN
+1.23%
$0.81
RIOT
-0.19%
$17.58
BTE
-2.54%
$2.48
RXRX
+4.67%
$4.93
ORCL
-1.59%
$296.60

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.